What is the best way of delivering virtual nature for improving mood? An experimental comparison of high definition TV, 360° video, and computer generated virtual reality von Yeo, N.L., White, M.P., Alcock, I., Garside, R., Dean, S.G., Smalley, A.J., Gatersleben, B.

Volltext

Dabrafenib; preclinical characterization, increased efficacy when combined with trametinib, while BRAF/MEK tool combination reduced skin lesions von King, Alastair J, Arnone, Marc R, Bleam, Maureen R, Moss, Katherine G, Yang, Jingsong, Fedorowicz, Kelly E, Smitheman, Kimberly N, Erhardt, Joseph A, Hughes-Earle, Angela, Kane-Carson, Laurie S, Sinnamon, Robert H, Qi, Hongwei, Rheault, Tara R, Uehling, David E, Laquerre, Sylvie G

Volltext

Routine multiplex mutational profiling of melanomas enables enrollment in genotype-driven therapeutic trials von Lovly, Christine M, Dahlman, Kimberly Brown, Fohn, Laurel E, Su, Zengliu, Dias-Santagata, Dora, Hicks, Donna J, Hucks, Donald, Berry, Elizabeth, Terry, Charles, Duke, MarKeesa, Su, Yingjun, Sobolik-Delmaire, Tammy, Richmond, Ann, Kelley, Mark C, Vnencak-Jones, Cindy L, Iafrate, A John, Sosman, Jeffrey, Pao, William

Volltext

Bolstering the transfer of expatriate training: A conceptual model integrating the roles of accountability and identity von Grossman, Rebecca, Burke‐Smalley, Lisa A., Panton, Kareem

Volltext

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy von Magnussen, Gry Irene, Holm, Ruth, Emilsen, Elisabeth, Rosnes, Anne Katrine Ree, Slipicevic, Ana, Flørenes, Vivi Ann

Volltext

Activation of Wnt/β-catenin signaling increases apoptosis in melanoma cells treated with trail von Zimmerman, Zachary F, Kulikauskas, Rima M, Bomsztyk, Karol, Moon, Randall T, Chien, Andy J

Volltext

Inter- and intra-patient heterogeneity of response and progression to targeted therapy in metastatic melanoma von Menzies, Alexander M, Haydu, Lauren E, Carlino, Matteo S, Azer, Mary W F, Carr, Peter J A, Kefford, Richard F, Long, Georgina V

Volltext

RASopathic skin eruptions during vemurafenib therapy von Rinderknecht, Jeannine D, Goldinger, Simone M, Rozati, Sima, Kamarashev, Jivko, Kerl, Katrin, French, Lars E, Dummer, Reinhard, Belloni, Benedetta

Volltext

Multiparametric analysis of cell-free DNA in melanoma patients von Salvianti, Francesca, Pinzani, Pamela, Verderio, Paolo, Ciniselli, Chiara Maura, Massi, Daniela, De Giorgi, Vincenzo, Grazzini, Marta, Pazzagli, Mario, Orlando, Claudio

Volltext

Long-term activation of TLR3 by poly(I:C) induces inflammation and impairs lung function in mice von Stowell, Nicole C, Seideman, Jonathan, Raymond, Holly A, Smalley, Karen A, Lamb, Roberta J, Egenolf, Devon D, Bugelski, Peter J, Murray, Lynne A, Marsters, Paul A, Bunting, Rachel A, Flavell, Richard A, Alexopoulou, Lena, San Mateo, Lani R, Griswold, Don E, Sarisky, Robert T, Mbow, M Lamine, Das, Anuk M

Volltext

Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype von Ho, Alan L, Musi, Elgilda, Ambrosini, Grazia, Nair, Jayasree S, Deraje Vasudeva, Shyamprasad, de Stanchina, Elisa, Schwartz, Gary K

Volltext

Activation of the PI3K/AKT pathway in Merkel cell carcinoma von Hafner, Christian, Houben, Roland, Baeurle, Anne, Ritter, Cathrin, Schrama, David, Landthaler, Michael, Becker, Juergen C

Volltext

Clinical profiling of BCL-2 family members in the setting of BRAF inhibition offers a rationale for targeting de novo resistance using BH3 mimetics von Frederick, Dennie T, Salas Fragomeni, Roberto A, Schalck, Aislyn, Ferreiro-Neira, Isabel, Hoff, Taylor, Cooper, Zachary A, Haq, Rizwan, Panka, David J, Kwong, Lawrence N, Davies, Michael A, Cusack, James C, Flaherty, Keith T, Fisher, David E, Mier, James W, Wargo, Jennifer A, Sullivan, Ryan J

Volltext

Comparison of testing methods for the detection of BRAF V600E mutations in malignant melanoma: pre-approval validation study of the companion diagnostic test for vemurafenib von Lopez-Rios, Fernando, Angulo, Barbara, Gomez, Belen, Mair, Debbie, Martinez, Rebeca, Conde, Esther, Shieh, Felice, Vaks, Jeffrey, Langland, Rachel, Lawrence, H Jeffrey, de Castro, David Gonzalez

Volltext

Prenylation inhibition-induced cell death in melanoma: reduced sensitivity in BRAF mutant/PTEN wild-type melanoma cells von Garay, Tamás, Kenessey, István, Molnár, Eszter, Juhász, Éva, Réti, Andrea, László, Viktória, Rózsás, Anita, Dobos, Judit, Döme, Balázs, Berger, Walter, Klepetko, Walter, Tóvári, József, Tímár, József, Hegedűs, Balázs

Volltext

A Novel SND1-BRAF Fusion Confers Resistance to c-Met Inhibitor PF-04217903 in GTL16 Cells though MAPK Activation von Lee, Nathan V, Lira, Maruja E, Pavlicek, Adam, Ye, Jingjing, Buckman, Dana, Bagrodia, Shubha, Srinivasa, Sreesha P, Zhao, Yongjun, Aparicio, Samuel, Rejto, Paul A, Christensen, James G, Ching, Keith A

Volltext

Seasonal Snowpack Microbial Ecology and Biogeochemistry on a High Arctic Ice Cap Reveals Negligible Autotrophic Activity During Spring and Summer Melt von Dayal, A., Hodson, A. J., Šabacká, M., Smalley, A. L.

Volltext

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension von Schuster, Cornelia, Eikesdal, Hans P, Puntervoll, Hanne, Geisler, Jürgen, Geisler, Stephanie, Heinrich, Daniel, Molven, Anders, Lønning, Per E, Akslen, Lars A, Straume, Oddbjørn

Volltext

Simultaneous inhibition of the HGF/MET and Erk1/2 pathways affect uveal melanoma cell growth and migration von Chattopadhyay, Chandrani, Grimm, Elizabeth A, Woodman, Scott E

Volltext

Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation von Molognoni, Fernanda, de Melo, Fabiana Henriques Machado, da Silva, Camila Tainah, Jasiulionis, Miriam Galvonas

Volltext